Skip to main content
Imaging the urokinase plasminongen activator receptor in preclinical breast cancer models of acquired drug resistance
Published Web Location
http://europepmc.org/articles/PMC3915090?pdf=renderNo data is associated with this publication.
Abstract
Subtype-targeted therapies can have a dramatic impact on improving the quality and quantity of life for women suffering from breast cancer. Despite an initial therapeutic response, cancer recurrence and acquired drug-resistance are commonplace. Non-invasiv
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.